Health Affairs December 1, 2024
Jenny S. Guadamuz, G. Caleb Alexander, Genevieve P. Kanter, Dima Mazen Qato

Abstract

In recent years, federal and state policy makers have expressed concern about retail pharmacy closures throughout the US. However, there is a dearth of timely information on the extent of such closures. We linked data from the National Council for Prescription Drug Programs on all US retail pharmacies to county-level data from the National Center for Health Statistics and ZIP Code Tabulation Area data from the American Community Survey to determine the number and percentage of pharmacy closures during the period 2010–21; identify pharmacy, neighborhood, and market characteristics associated with pharmacy closure; and estimate the risk for closure...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
STAT+: DeepSeek signals China’s rising influence in AI — and AI drug development
Is 2025 the Chinese Year of BioPharma?
Pharma Pulse 2/3/25: The Rundown on Rebates, GLP-1s and Pharmacists' Role & more
Inflation Reduction Act Unintended Consequences For Medical Innovation
Building Resilience: CDMO Strategies for Drug Supply Chain Stability

Share This Article